Abstract:This paper describes the characterization of solid lipid nanodispersions (SLN) prepared with a 1:1 mixture of theobroma oil and goat fat as the main lipid matrix and Phospholipon 90G (P90G) as a stabilizer heterolipid, using polysorbate 80 as the mobile surfactant, with a view to applying the SLN in drug delivery. The 1:1 lipid mixture and P90G constituting the lipid matrix was first homogeneously prepared by fusion. Thereafter, the SLN were formulated with a gradient of polysorbate 80 and constant lipid matrix concentration by melt-high pressure homogenisation. The SLN were characterized by time-resolved particle size analysis, zeta potential and osmotic pressure measurements, differential scanning calorimetry (DSC) and wide angle X-ray diffraction (WAXD). Transmission electron microscopy (TEM) and isothermal heat conduction microcalorimetry (IMC) which monitors the in situ crystallization were also carried out on the SLN containing P90G and 1.0 % w/w of polysorbate 80. The results obtained in these studies were compared with SLN prepared with theobroma oil with and without phospholipid. Particle size analysis of SLN indicated reduction in size with increase in concentration of mobile surfactant and was in the lower nanometer range after 3 months except SLN prepared without P90G or polysorbate 80. The lipid nanoparticles had negative potentials after 3 months. WAXD and DSC studies revealed low crystalline SLN after 3 months of storage except in WAXD of SLN formulated with 1.0 % w/w polysorbate 80. TEM micrograph of the SLN containing 1.0 % w/w polysorbate 80 revealed discrete particles whose sizes were in consonance with the static light scattering measurement. In situ crystallization studies in IMC revealed delayed crystallization of the SLN with 1.0 % w/w polysorbate 80. Results indicate lipid mixtures produced SLN with lower crystallinity and higher particle sizes compared with SLN prepared with theobroma oil alone with or without P90G, and would lead to higher drug incorporation efficiency when used in formulation of actives. Mixtures of theobroma oil and goat fat would be suitable for the preparation of nanostructured lipid carriers. SLN of theobroma oil containing phospholipid could prove to be a good ocular or parenteral drug delivery system considering the low particle size, particle size stability and in vivo tolerability of the component lipids. SLN prepared with lipid admixture, which had higher increase in d(90%) on storage are suitable for preparation of topical and transdermal products.

Formulation and Characterization of Hydrophilic Drug Diclofenac Sodium-Loaded Solid Lipid Nanoparticles Based on Phospholipid Complexes Technology.

Single-component Solid Lipid Nanocarriers Prepared with Ultra-Long Chain Amphiphilic Lipids.

Synthetic Ultra-Long Chain Fatty Acyl Based Amphiphilic Lipids As A Dual Function Excipient for the Production of Surfactant-Free Solid Lipid Nanoparticles (Sf-Slns): A Physico-Chemical Study

Diclofenac Sodium-Loaded Solid Lipid Nanoparticles Prepared by Emulsion/solvent Evaporation Method

Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies.

Experiment on Lornoxicam-Loaded Solid Lipid Nanoparticles

Preparation and Characterization of Diclofenac Sodium Layered Double Hydroxide Nanohybrids

Preparation and pharmacodynamic evaluation of sodium aescinate solid lipid nanoparticles

Preparation, Characterization, and in Vitro Release of Chloramphenicol Loaded Solid Lipid Nanoparticles

Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization

Diclofenac Loaded Lipid Based Microparticulate Drug Delivery System for Osteoarthritis

Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.

Structural Characterization of Novel Phospholipid Lipid Nanoparticles for Controlled Drug Delivery

Effect of the Cargo Lipophilicity on Powder Micromeritics Properties of Drug-Loaded Solid Lipid Microparticles

Solid Lipid Nanoparticles Prepared by Solvent Diffusion Method in a Nanoreactor System

The Production and Characteristics of Solid Lipid Nanoparticles (Slns).

A Novel Strategy for Encapsulating Poorly Soluble Drug into Nanostructured Lipid Carriers for Intravenous Administration

Preparation of Stable Solid Lipid Nanoparticles (slns) Suspension with Combined Surfactants

Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis

Preparation, Characterization and Pharmacokinetics of Tolfenamic Acid-Loaded Solid Lipid Nanoparticles

Structure Analysis of Solid Lipid Nanoparticles for Drug Delivery: A Combined USANS/SANS Study